TrialNeuropsychiatric disease and treatment2021

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study.

Masaomi Iyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.